TABLE 2.
Drug |
n (n BLQ) |
Median (range) % of MLN area covered by ARV |
Median (range) % of heme-corrected ARV area >IC50 (BLQs excluded) |
IC50 value (ng/g of tissue) |
IC50 reference | ||
---|---|---|---|---|---|---|---|
Raw | Heme corrected | P | |||||
FTC | 17 (11) | 1.6 (0.09–11) | 1.6 (0.07–11) | NS | 100 (95–100) | 149 | 35 |
TFV | 17 (3) | 8.4 (0.1–71) | 7.8 (0.1–71) | NS | 97 (23–100) | 2,303 | 34 |
EFV | 8 (0) | 22 (5.2–77) | 22 (4.9–76) | NS | 100 (100–100) | 11.9b | 41 |
RAL | 8 (7) | 0.10 (0.03–0.42) | 0.08 (0.03–0.42) | NS | 100 (100–100) | 2.9 | 42 |
MVC | 9 (0) | 79 (56–97) | 79 (55–96) | NS | 100 (100–100) | 2.2 | 43 |
ATV | 9 (3) | 3.3 (1.2–97) | 3.2 (1–96) | NS | 100 (100–100) | 16.6b | 44 |
Cumulative | 17 | 70 (5.8–99) | 69 (5.4–98) | NS |
Mann-Whitney rank sum test. NS, not significant.
Protein binding adjusted.